Feasibility of Safe Opioid Prescribing in Outpatient Palliative Care: A Quality Improvement Project.

Abstract

BACKGROUND\nNo guidelines for safe opioid prescribing in palliative care exist, which contributes to limited monitoring of opioid misuse in palliative care.\n\n\nMEASURES\nFeasibility of a safe opioid prescribing standard operating protocol (SOP) was determined by assessing the percentage of patients in an outpatient cancer center who completed each component of a five-component SOP.\n\n\nINTERVENTION\nA five-component SOP included: risk stratification for misuse, consent form, prescription drug monitoring program review, urine drug testing, and Naloxone for high-risk individuals.\n\n\nOUTCOMES\nAfter one year, compliance rates on four of the of the five-component SOP were greater or equal to 93%. Naloxone co-prescription for high-risk patients never reached over 78%, largely due to clinical decision not to co-prescribe if transition to hospice was imminent.\n\n\nCONCLUSIONS/LESSONS LEARNED\nSafe opioid prescribing measures is feasible in outpatient palliative care and can facilitate identification of individuals at risk for opioid misuse and prompt early interventions for misuse.